A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Phase 1
Suspended
- Conditions
- Ovarian Cancer
- Interventions
- Device: ThermalCore Hyperthermia System
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- ThermalCore Inc
- Target Recruit Count
- 20
- Registration Number
- NCT02093871
- Locations
- 🇺🇸
Good Samaritan Hospital, San Jose, California, United States
© Copyright 2025. All Rights Reserved by MedPath